The early detection of the onset of transplant rejection is critical for the long-term survival of
patients. The diagnostic gold standard for detecting transplant rejection involves a core …

Immune checkpoint blockade (ICB) therapy does not benefit the majority of treated patients,
and those who respond to the therapy can become resistant to it. Here we report the design …

Abstract Background While cesarean sections (CSs) are a life-saving intervention, an
increasing number are performed without medical reasons in low-and middle-income …

The clinical success of cancer immunotherapy is providing exciting opportunities for the
development of new methods to detect and treat cancer more effectively. A new generation …

Background Women's empowerment, and maternal and neonatal health are important
targets of the Sustainable Development Goals. Our objective is to examine the relationship …

Background Improving the understanding of non-clinical factors that lead to the increasing
caesarean section (CS) rates in many low-and middle-income countries is currently …

Objective To measure the proportion of women's preferences for CS in hospitals with high
caesarean section rates and to identify related factors. Design A cross-sectional hospital …

Proteases are multi-functional enzymes that specialize in the hydrolysis of peptide-bonds
and control broad biological processes including homeostasis and allostasis. Moreover …

Immune checkpoint blockade (ICB) therapy has transformed the clinical care of cancer, yet
the majority of patients do not derive clinical benefit and responders can acquire resistance …

Along the patient continuum of care, the ability to detect disease early has a significant
impact on the successful outcome of a patient's treatment. As healthcare challenges …